Ụlọ ọrụ GMP na-eweta Antineoplastic ntụ ntụ Cabazitaxel CAS 183133-96-2

Ozi ngwaahịa

Aha:Cabazitaxel

Nọmba CAS:183133-96-2

Usoro kemịkalụ:C45H57NO14

Nkọwapụta:99%

Agba:ọcha ma ọ bụ na-acha ọcha ntụ ntụ

Isi mmalite:Semi-synthesized na 10-DAB

Ụdị:API

Akụkọ ihe mere eme nke Hande GMP

1. Na 1996, e guzobere usoro mma ma nweta DMF.

2. Na 2004, FDA on-site nnyocha nwetara CGMP akwụkwọ.

3. Na 2009, a na-enweta paclitaxel semi-synthetic DMF na paclitaxel CEP eke.

4. N'afọ 2011, e nwetara paclitaxel CEP semi-synthetic.

5. Na 2012, gafere nyocha TGA na saịtị, nweta asambodo GMP, wee gafee nyocha nke saịtị FDA.

6. Na 2013, gafere saịtị CGMP.

7. N'afọ 2015, e debanyere aha India na aha Japan.

Hande mmepụta ike

Usoro mmepụta:30-45 ụbọchị.

Ogbe mmepụta:Otu ogbe nwere ike iwepụta ihe dị ka kilogram 15.

Ike mmepụta Hande:enwere ngwaahịa na enwere ike imepụta ọtụtụ.

Ndị ahịa Hande

Ahịa Hande na-ekpuchi North America, Europe, Australia, India, Southeast Asia na China.

Ọtụtụ n'ime ndị ahịa a na-eji ngwaahịa anyị maka nnwale ụlọ ọgwụ ga-anabata maka ire ahịa na 2018-2019.

Ụlọ ọrụ Hande

Yunnan hande Biotechnology Co., Ltd., tọrọ ntọala na August 1993, bụ ụlọ ọrụ teknụzụ dị elu nke ọkachamara na nyocha na mmepe biotechnology.Mgbe ọtụtụ afọ nke mmepe gasịrị, hande eguzobewo usoro dị mma zuru oke, na-achịkwa àgwà ngwaahịa dịka ụkpụrụ dị elu si dị, ma mee ka uru mmepụta nke mmepụta ihe dị elu.Ngwaahịa ya agafeela asambodo nke iwu na ụkpụrụ mba dị iche iche, wee bụrụ onye nrụpụta akụrụngwa akụrụngwa nke na-eme onye ọ bụla nwee ahụ iru ala.